Since AD patients with psychoses display an increase in beta-amyloid (Aβ42/40) ratio as well as decreased Kalirin levels, loss of KALRN expression has been correlated with AD pathology [1], while Kalirin-7 pharmacological activation may be protective in AD, preventing or delaying synapse pathology [11]. This evidence concerns the gene KALRN and Alzheimer disease.